Neurotech International Limited announced the passing of Professor Allan Cripps AO, Non-Executive Director and Chief Scientist of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 AUD | -3.23% | -15.49% | -13.04% |
06-06 | Easing Rate Hike Concerns Shore Up Australian Shares | MT |
06-06 | Neurotech's Extended NTI164 Drug Trial Yields Further Improvements; Shares Surge Nearly 11% | MT |
1st Jan change | Capi. | |
---|---|---|
-13.04% | 40.19M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- NTI Stock
- News Neurotech International Limited
- Neurotech International Limited Announces Passing of Professor Allan Cripps AO, Non-Executive Director